Literature DB >> 23291124

Activated CD8 T cells acquire NK1.1 expression and preferentially locate in the liver in mice after allogeneic hematopoietic cell transplantation.

Yi Wang1, Hui Wang, Jinxing Xia, Tingting Liang, Guanjun Wang, Xiaokun Li, Yong-Guang Yang.   

Abstract

Immune cells expressing both NK and T cell markers include CD1d-dependent NKT cells and CD1d-independent NKT-like cells. We now describe the presence of NK1.1(+)CD8(+) T cells in the liver, but not other tissues (spleen, bone marrow, thymus or peripheral blood) in mice receiving allogeneic hematopoietic cell transplantation (allo-HCT). These cells are CD1d-independent TCRαβ(+) T cells with an effector/memory CD44(hi)CD62L(-) phenotype, and do not express Ly49 receptors. Furthermore, these cells were derived from donor splenocytes, but not bone marrow cells. Depletion of CD8(+), but not NK1.1(+), cells from donor splenocytes prior to transplantation prevented the generation of NK1.1(+)CD8(+) T cells, indicating that these cells arose from donor NK1.1(-)CD8(+) splenic T cells. These results provide direct evidence that donor CD8(+) T cells can acquire NK1.1 expression upon activation in allo-HCT recipients and that these NK1.1(+)CD8(+) NKT-like cells maintain an effector/memory phenotype and persist in the recipients with preferential localization in the liver.
Copyright © 2012 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23291124      PMCID: PMC3602380          DOI: 10.1016/j.imlet.2012.12.009

Source DB:  PubMed          Journal:  Immunol Lett        ISSN: 0165-2478            Impact factor:   3.685


  12 in total

1.  NK markers are expressed on a high percentage of virus-specific CD8+ and CD4+ T cells.

Authors:  M K Slifka; R R Pagarigan; J L Whitton
Journal:  J Immunol       Date:  2000-02-15       Impact factor: 5.422

2.  CD8+ T cells rapidly acquire NK1.1 and NK cell-associated molecules upon stimulation in vitro and in vivo.

Authors:  E Assarsson; T Kambayashi; J K Sandberg; S Hong; M Taniguchi; L Van Kaer; H G Ljunggren; B J Chambers
Journal:  J Immunol       Date:  2000-10-01       Impact factor: 5.422

3.  Tissue-specific segregation of CD1d-dependent and CD1d-independent NK T cells.

Authors:  G Eberl; R Lees; S T Smiley; M Taniguchi; M J Grusby; H R MacDonald
Journal:  J Immunol       Date:  1999-06-01       Impact factor: 5.422

4.  Expansion and function of CD8+ T cells expressing Ly49 inhibitory receptors specific for MHC class I molecules.

Authors:  Nicolas Anfossi; Scott H Robbins; Sophie Ugolini; Philippe Georgel; Kasper Hoebe; Cécile Bouneaud; Catherine Ronet; Arthur Kaser; Catherine B DiCioccio; Elena Tomasello; Richard S Blumberg; Bruce Beutler; Steven L Reiner; Lena Alexopoulou; Olivier Lantz; David H Raulet; Laurent Brossay; Eric Vivier
Journal:  J Immunol       Date:  2004-09-15       Impact factor: 5.422

Review 5.  NKT cells: what's in a name?

Authors:  Dale I Godfrey; H Robson MacDonald; Mitchell Kronenberg; Mark J Smyth; Luc Van Kaer
Journal:  Nat Rev Immunol       Date:  2004-03       Impact factor: 53.106

Review 6.  Presumed guilty: natural killer T cell defects and human disease.

Authors:  Stuart P Berzins; Mark J Smyth; Alan G Baxter
Journal:  Nat Rev Immunol       Date:  2011-02       Impact factor: 53.106

7.  NKT cells are phenotypically and functionally diverse.

Authors:  K J Hammond; S B Pelikan; N Y Crowe; E Randle-Barrett; T Nakayama; M Taniguchi; M J Smyth; I R van Driel; R Scollay; A G Baxter; D I Godfrey
Journal:  Eur J Immunol       Date:  1999-11       Impact factor: 5.532

8.  Emergence of CD8+ T cells expressing NK cell receptors in influenza A virus-infected mice.

Authors:  T Kambayashi; E Assarsson; J Michaëlsson; P Berglund; A D Diehl; B J Chambers; H G Ljunggren
Journal:  J Immunol       Date:  2000-11-01       Impact factor: 5.422

9.  Expansion of cytolytic CD8(+) natural killer T cells with limited capacity for graft-versus-host disease induction due to interferon gamma production.

Authors:  J Baker; M R Verneris; M Ito; J A Shizuru; R S Negrin
Journal:  Blood       Date:  2001-05-15       Impact factor: 22.113

10.  The IL-10 and IFN-gamma pathways are essential to the potent immunosuppressive activity of cultured CD8+ NKT-like cells.

Authors:  Li Zhou; Hongjie Wang; Xing Zhong; Yulan Jin; Qing-Sheng Mi; Ashok Sharma; Richard A McIndoe; Nikhil Garge; Robert Podolsky; Jin-Xiong She
Journal:  Genome Biol       Date:  2008-07-29       Impact factor: 13.583

View more
  5 in total

1.  Dissecting CD8+ NKT Cell Responses to Listeria Infection Reveals a Component of Innate Resistance.

Authors:  Sergey S Seregin; Grace Y Chen; Yasmina Laouar
Journal:  J Immunol       Date:  2015-06-26       Impact factor: 5.422

2.  Proteomic analysis reveals distinctive protein profiles involved in CD8+ T cell-mediated murine autoimmune cholangitis.

Authors:  Weici Zhang; Ren Zhang; Jun Zhang; Ying Sun; Patrick Sc Leung; Guo-Xiang Yang; Zongwen Shuai; William M Ridgway; M Eric Gershwin
Journal:  Cell Mol Immunol       Date:  2018-01-29       Impact factor: 11.530

Review 3.  CD8+CD161+ T-Cells: Cytotoxic Memory Cells With High Therapeutic Potential.

Authors:  Vanaja Konduri; Damilola Oyewole-Said; Jonathan Vazquez-Perez; Scott A Weldon; Matthew M Halpert; Jonathan M Levitt; William K Decker
Journal:  Front Immunol       Date:  2021-02-01       Impact factor: 7.561

4.  iNKT Cells Suppress Pathogenic NK1.1+CD8+ T Cells in DSS-Induced Colitis.

Authors:  Sung Won Lee; Hyun Jung Park; Jae Hee Cheon; Lan Wu; Luc Van Kaer; Seokmann Hong
Journal:  Front Immunol       Date:  2018-10-02       Impact factor: 7.561

5.  Unveiling the heterogeneity of NKT cells in the liver through single cell RNA sequencing.

Authors:  Hao Shen; Chan Gu; Tao Liang; Haifeng Liu; Fan Guo; Xiaolong Liu
Journal:  Sci Rep       Date:  2020-11-10       Impact factor: 4.379

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.